Connor, Clark & Lunn Investment Management (CC&L)’s Cellebrite CLBT Stock Holding History

Connor, Clark & Lunn Investment Management (CC&L)’s Portfolio CLBT Stock Details CLBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-581,744	Closed	-$11.3M	–	1535
2025 Q1	$11.3M	Sell	581,744 -325,883	-36%	-$6.86M	0.05%	297
2024 Q4	$20M	Sell	907,627 -241,356	-21%	-$4.65M	0.09%	171
2024 Q3	$19.3M	Sell	1,148,983 -79,151	-6%	-$1.17M	0.09%	172
2024 Q2	$14.7M	Buy	1,228,134 +18,818	+2%	+$210K	0.06%	227
2024 Q1	$13.4M	Buy	1,209,316 +476,432	+65%	+$4.86M	0.06%	256
2023 Q4	$6.35M	Hold	732,884	–	–	0.03%	358
2023 Q3	$5.61M	Buy	732,884 +422,057	+136%	+$3.17M	0.03%	365
2023 Q2	$2.24M	Buy	310,827 +153,830	+98%	+$897K	0.01%	584
2023 Q1	$956K	Buy	+156,997	New	+$851K	0.01%	726

Other funds holding CLBT

TWCM

True Wind Capital Management San Francisco, California $226M AUM 2.79% 1-Year Est. Return

Axon Enterprise Scottsdale, Arizona $18.1M AUM 29.08% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Voss Capital Houston, Texas $1.88B AUM 1.03% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Pertento Partners London, United Kingdom $1.37B AUM 36.36% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)'s CLBT Position: Q2 2025 in Review

Connor, Clark & Lunn Investment Management (CC&L) sold out of Cellebrite (CLBT) in Q2 2025, closing a stake of 581,744 shares — an estimated $11.3M sold.

Connor, Clark & Lunn Investment Management (CC&L) first reported a position in CLBT in Q1 2023 and held it in 9 quarters. The position peaked at $20M in Q4 2024. 209 funds tracked by Wall St. Rank hold CLBT as of Q2 2025.

Connor, Clark & Lunn Investment Management (CC&L) reported no remaining Cellebrite position as of Q2 2025 after selling out during the quarter.
Connor, Clark & Lunn Investment Management (CC&L) sold 581,744 Cellebrite shares in Q2 2025, an estimated $11.3M.
Connor, Clark & Lunn Investment Management (CC&L) first reported a position in Cellebrite in Q1 2023 and held it in 9 quarters.
Connor, Clark & Lunn Investment Management (CC&L)'s Cellebrite position peaked at $20M in Q4 2024.
209 funds tracked by Wall St. Rank held Cellebrite as of Q2 2025.

Based on Connor, Clark & Lunn Investment Management (CC&L)'s 13F filing for Q2 2025, filed 7 Aug 2025.